Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
51.6M
-
Number of holders
-
72
-
Total 13F shares, excl. options
-
14.4M
-
Shares change
-
-1.95M
-
Total reported value, excl. options
-
$38.4M
-
Value change
-
-$6.42M
-
Put/Call ratio
-
0.16
-
Number of buys
-
28
-
Number of sells
-
-27
-
Price
-
$2.67
Significant Holders of ACHIEVE LIFE SCIENCES, INC. - Common Stock, par value $0.001 per share (ACHV) as of Q1 2025
81 filings reported holding ACHV - ACHIEVE LIFE SCIENCES, INC. - Common Stock, par value $0.001 per share as of Q1 2025.
ACHIEVE LIFE SCIENCES, INC. - Common Stock, par value $0.001 per share (ACHV) has 72 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14.4M shares
of 51.6M outstanding shares and own 27.89% of the company stock.
Largest 10 shareholders include FRANKLIN RESOURCES INC (2.46M shares), Propel Bio Management, LLC (2.45M shares), BlackRock, Inc. (2.05M shares), VANGUARD GROUP INC (1.72M shares), Nantahala Capital Management, LLC (899K shares), GEODE CAPITAL MANAGEMENT, LLC (769K shares), STATE STREET CORP (453K shares), Alyeska Investment Group, L.P. (421K shares), NORTHERN TRUST CORP (404K shares), and J. Goldman & Co LP (294K shares).
This table shows the top 72 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.